Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G3ZX
|
|||
| Former ID |
DIB003068
|
|||
| Drug Name |
Omri-Hep-B
|
|||
| Synonyms |
HBIG; Immunoglobulin therapy (hepatitis B), OMRIX
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 1 | [1] | |
| Company |
OMRIX Biopharmaceuticals SA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C2H7N5
|
|||
| Canonical SMILES |
C(=NC(=N)N)(N)N
|
|||
| InChI |
1S/C2H7N5/c3-1(4)7-2(5)6/h(H7,3,4,5,6,7)
|
|||
| InChIKey |
XNCOSPRUTUOJCJ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 56-03-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9874, 7806164, 7820942, 8153685, 11533497, 15461801, 29224964, 50691704, 57323065, 92251317, 104310674, 115944933, 118313733, 121379932, 125335787, 126648653, 127307883, 127307884, 127307885, 127307886, 127307887, 127307888, 127307889, 127307890, 127307891, 127307892, 129712660, 131318925, 132556129, 134972450, 135305927, 135317492, 135889051, 137003516, 137006902, 142260542, 152033957, 162548286, 163302751, 164832788, 179095101, 184528578, 196105806, 198969807, 223735978, 224132469, 226399313
|
|||
| ChEBI ID |
CHEBI:3095
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation. Hepatology. 1999 Apr;29(4):1299-305. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.